Citations

Showing 10 of 108119 citations.

Native American patients’ perception and attitude about kidney transplant: a qualitative assessment of patients presenting for kidney transplant evaluation
Keddis, Mira T. , Finnie, Dawn, Kim, Wonsun (Sunny), Kim, Sunny , Keddis, Mira , Finnie, Dawn M., Kim, Wonsun (Sunny)

Mayo Clinic

BMJ Open | January 29, 2019 | Volume: 9 | Issue: 1 | Pages: e024671

10.1136/bmjopen-2018-024671 | PMID 30696683 Get It

Objective Native Americans suffer from lower rates of kidney transplantation compared with whites. Our goal was to elicit patients’ perceptions of and attitudes about kidney transplant and the impact of financial burden and cultural taboos. Design This is an exploratory qualitative interview study of 12 Native American patients recruited after completion of the kidney transplant evaluation. Setting Semistructured interviews were conducted. Interviews were coded using inductive methods, followed by interpretive coding by the investigators. Results Thematic analysis revealed the following themes: (1) experience with kidney transplant education by the healthcare team; (2) cultural beliefs regarding kidney transplant; (3) personal motivation and attitude towards kidney transplant; (4) financial burden of kidney transplant and post-transplant care and (5) attitude about living donation. Most participants were educated about transplant as a treatment option after dialysis initiation. All patients in this study recognised that some taboos exist about the process of organ procurement and transplantation; however, the traditional views did not negatively impact their decision to pursue kidney transplant evaluation. Patients shared the common theme of preferring an organ from a living rather than a deceased person; however, the majority did not have a living donor and preferred not to receive an organ from a family member. Most patients did not perceive transplant-related cost as negatively impacting their attitude about receiving a transplant even for patients with below poverty level income. Conclusions Native American patients presenting for kidney transplant were less likely to be educated about transplant before dialysis initiation; did not perceive financial burden and cultural beliefs were not discussed as obstacles to transplant. While a living donor was the preferred option, enthusiasm for living donation from family members was limited.
Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response
Zarb, Yvette , Weber‐Stadlbauer, Ulrike , Kirschenbaum, Daniel S. , Kindler, Diana, Richetto, Juliet , Rademakers, Rosa , Byzova, Tatiana V. , Nahar, Khayrun, Voigt, Fabian F. , Helmchen, Fritjof , Boss, Andreas , Aguzzi, Adriano , Klohs, Jan , Keller, Annika , Pasch, Andreas, Keller, Daniel X. , Dickson, Dennis W. , Pasch, Andreas

Mayo Clinic

Brain | January 29, 2019 | Volume: 142 | Issue: 4 | Pages: 885-902

10.1093/brain/awz032 | PMID 30805583 Get It

Increased Accuracy, Confidence, and Efficiency in Anterior Ethmoidal Artery Identification with Segmented Image Guidance
Itayem, Deeyar A., Anzalone, C. Lane , White, James R. , Pallanch, John F., O’Brien, Erin K. , O'Brien, Erin K , White, James R.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 29, 2019 | Volume: 160 | Issue: 5 | Pages: 818-821

10.1177/0194599818825454 | PMID 30691346 Get It

ObjectiveTo determine whether using image guidance technology with 3‐dimensional image segmentation increases the endoscopic surgeon's accuracy, efficiency, and confidence in identifying the anterior ethmoidal artery.MethodsThis is a cross‐sectional study of attending physicians and residents at an academic medical center. Because identification of the anterior ethmoidal artery during image‐guided surgery can be challenging, we studied the effect of anterior ethmoidal artery image segmentation (ie, partitioning and coloring) on surgeon test performance. A computerized test was administered to 16 surgeons who were asked to identify the anterior ethmoidal artery on multiplanar computed tomographic images and to answer multiple‐choice questions. Half the questions showed segmented images of the anterior ethmoidal artery, and half showed images without segmentation. Efficiency and accuracy of identification and subjective surgeon confidence were determined for each question. Descriptive statistics were used to compare test performance for identification of the anterior ethmoidal artery on images with or without segmentation.ResultsPercentage of correct answers (P <. 001), efficiency (P <. 001), and confidence (P <. 001) in identification of the anterior ethmoidal artery were significantly better with segmented computed tomographic images.DiscussionWe demonstrated that use of segmented images improves surgeons’ accuracy, confidence, and efficiency for identification of the anterior ethmoidal artery.Implications for PracticeWe describe how segmentation can allow surgeons to improve the surgical course by increasing their accuracy, confidence, and efficiency in identifying the anterior ethmoidal artery.
Contemporary Imaging Diagnosis of Cardiac Amyloidosis
Lee, Seung‐Pyo , Park, Jun‐Bean , Kim, Hyung‐Kwan , Kim, Yong‐Jin , Grogan, Martha , Sohn, Dae‐Won , Grogan, Martha , Kim, Hyung-Kwan

Mayo Clinic

Journal of Cardiovascular Imaging | January 29, 2019 | Volume: 27 | Issue: 1 | Pages: 1

10.4250/jcvi.2019.27.e9 | PMID 30701710 Get It

Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review
Marinelli, John P. , Peters, Pierce A., Lane, John I. , Carlson, Matthew L. , Vaglio, Augusto , Gompel, Jamie J. Van

Mayo Clinic

Neurosurgery | January 28, 2019 | Volume: 85 | Issue: 4 | Pages: E693-E701

10.1093/neuros/nyz027 | PMID 30828728 Get It

Abstract BACKGROUND Erdheim-Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis. Up to 50% of patients develop central nervous system involvement, and a subset of these patients can present with isolated tumor-like masses. OBJECTIVE To describe the skull base manifestations of ECD with an emphasis on aspects most pertinent to surgeons who may be referred such patients for primary evaluation. METHODS Scopus, Web of Science, and PubMed were searched from database inception to May 1, 2018 for articles reporting skull base ECD. An institutional retrospective analysis of all patients treated at the authors’ institution since January 1, 1996 was also performed to supplement these data. RESULTS Of 465 retrieved articles, 18 studies totaling 20 patients met inclusion criteria. Institutional review identified an additional 7 patients. Collectively, the median age at diagnosis was 49 yr (interquartile range, 42-58) with a 4:1 male-to-female ratio. Patients frequently presented with diplopia (48%), headache (30%), dysarthria (22%), and vertigo or imbalance (22%), though trigeminal hypesthesia (11%), facial nerve paresis (7%), hearing loss (7%), and trigeminal neuralgia (7%) were also observed. ECD commonly mimicked meningioma (33%), trigeminal schwannoma (8%), neurosarcoidosis (8%), and skull base lymphoma (8%). CONCLUSION Discrete skull base lesions frequently mimic more common pathology such as meningioma or cranial nerve schwannomas. Medical therapy comprises the initial treatment for symptomatic skull base disease. Surgical resection is not curative and the utility of surgical intervention is largely limited to biopsy to establish diagnosis and/or surgical debulking to relieve mass effect.
Gastrointestinal: Positron emission tomography–computed tomography imaging of multifocal intestinal metastasis from primary lung cancer
Nguyen, BD, Ryan, M

Mayo Clinic

Journal of Gastroenterology and Hepatology | January 28, 2019 | Volume: 34 | Issue: 5 | Pages: 814-814

10.1111/jgh.14591 | PMID 30693593 Get It

Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
Personett, Heather A. , Kayhart, Bryce M., Frazee, Erin N. , Tosh, Pritish K. , Dierkhising, Ross , Mara, Kristin C. , May, Heather P. , Frazee, Erin N , Tosh, Pritish , Mara, Kristin, Mara, Kristin C , Leung, Nelson

Mayo Clinic

International Journal of Nephrology | January 28, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-8

10.1155/2019/8629891 | PMID 30809394 Get It

Background. Acute kidney injury (AKI) is a common complication of treatment with liposomal amphotericin B (LAmB). The trajectory of renal recovery after LAmB-associated AKI has not been well described, nor has effect of LAmB dose on recovery of renal function been explored. Objective. Characterize the pattern of renal recovery after incident AKI during LAmB and determine potential influencing factors. Methods. This retrospective cohort study analyzed patients who developed a ≥50% increase in serum creatinine while on LAmB. Patients were followed up until complete renal recovery or death or for 30 days, whichever occurred first. The primary outcome was complete renal recovery, defined as serum creatinine convalescence to within 10% of the patient’s pretreatment baseline. Multivariable modeling was used to identify independent predictors of renal recovery. Results. Ninety-eight patients experienced nephrotoxicity during LAmB, 94% of which received doses <7 mg/kg/day. Fifty-one patients at least partially recovered renal function and, of these, 32 exhibited complete recovery after a mean 9.8 ± 7.8 days. No statistical relationship was found between LAmB dose at the time of AKI or cumulative exposure to LAmB and the likelihood of renal recovery. Concomitant nephrotoxins, age, and pretreatment renal function did not modify this effect in multivariable analysis. Conclusion and Relevance. Our data suggests that LAmB dose did not impact the likelihood of renal recovery. Additional investigation is needed to confirm these findings when aggressive dosing strategies are employe. Additional research is also warranted to further characterize the course of recovery after LAmB-associated nephrotoxicity and comprehensive spectrum of renal outcomes.
Predictors of mortality in patients with non‐anterior ST‐segment elevation myocardial infarction: Analysis from the HORIZONS‐AMI trial
Huang, Xin , Redfors, Björn , Mehran, Roxana , Zhang, Yiran , McAndrew, Thomas , Ben‐Yehuda, Ori , Mintz, Gary S. , Stone, Gregg W. , Mehran, Roxana , Chen, Shmuel , Gersh, Bernard J.

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 28, 2019 | Volume: 94 | Issue: 2 | Pages: 172-180

10.1002/ccd.28096 | PMID 30690854 Get It

Abstract Objectives We sought to identify clinical, electrocardiographic (ECG), and angiographic characteristics that are predictive of 3‐year mortality after primary percutaneous coronary intervention (PCI) in patients with non‐anterior ST‐elevation myocardial infarction (NA‐STEMI) from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) trial. Background Which patients with NA‐STEMI undergoing PCI have a poor prognosis is uncertain. Methods NA‐STEMI was defined as ST‐segment elevation in lateral (V5, V6, I, aVL), inferior (II, III, aVF), or inferolateral (I, II, III, aVF, and V5‐V6) ECG leads or posterior myocardial infarction with ST‐segment depression of ≥1 mm in ≥2 contiguous anterior leads. Cox regression was used to identify independent predictors of 3‐year mortality. Missing data were imputed using multiple imputation. Results In HORIZONS‐AMI, 2,578/3,602 patients had no prior coronary artery bypass grafting, underwent single‐vessel PCI, and had baseline ECG data assessed in an independent core laboratory. Among them, 1,495 (58.0%) had NA‐STEMI. Patients with NA‐STEMI had lower 3‐year mortality risk than those with anterior STEMI (4.5% versus 7.1%, P = 0.004). The independent predictors of increased 3‐year mortality in NA‐STEMI were older age (median > 59.0 years), diabetes, reduced LVEF (≤50%), Killip class ≥2, post‐procedure TIMI flow 0–2 versus 3, renal insufficiency, and ST‐resolution <30% at 60 min post‐PCI. Patients with 0, 1, 2, 3, and ≥4 of these risk factors had 3‐year mortality rates of 1.8%, 2.3%, 3.1%, 6.1%, and 36.3%, respectively ( P < 0.0001). Conclusions Although NA‐STEMI carries a better prognosis than anterior STEMI, high‐risk patient cohorts with NA‐STEMI may be identified who have substantial 3‐year mortality.
The Now and Beyond of Tumor Mutational Burden as a Predictor of Response to Immune Checkpoint Inhibitors
Nandakumar, Vijayalakshmi, Mills, John R.

Mayo Clinic

Clinical Chemistry | January 28, 2019 | Volume: 65 | Issue: 2 | Pages: 357-357

10.1373/clinchem.2018.295097 | PMID 32100826 Get It

A Question of Opioid Diversion or Compliance
Cervinski, Mark A , Jannetto, Paul J. , Cervinski, Mark A

Mayo Clinic

Clinical Chemistry | January 28, 2019 | Volume: 65 | Issue: 2 | Pages: 236-240

10.1373/clinchem.2018.294140 | PMID 30692135 Get It